Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.39.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.233ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.233ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.233ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.233NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.320ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.320ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.320ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.320NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.635ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.635ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.635ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.635NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
AY.19 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.19 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.19 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.19 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-17710.7China
N.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
AM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AM.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.15 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.15 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.15 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.15 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.113ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used